Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease
Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730 PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In…[...]
Read More